Avidity Biosciences vs Cellcolabs
Avidity Biosciences vs Cellcolabs, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Avidity Biosciences is on 53/100 and Cellcolabs on 55/100.
Where each one leads
Avidity Biosciences
- domain rating: 46/100 against 37/100
- headcount: 445 against 79
- funding raised: $495M against $15.5M
- LinkedIn following: 37,705 against 6,563
Cellcolabs
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Avidity Biosciences | Cellcolabs |
|---|---|---|
| What it is | Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases. | AI-powered platform for personalized cell therapy development and manufacturing. |
| Category | Biotech, Drug Discovery, Genomics, Clinical Trials | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2013 | 2021 |
| Headquarters | San Diego, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Avidity Biosciences | Cellcolabs |
|---|---|---|
| Employees | 445 | 79 |
| Total funding | $495M | $15.5M |
| Latest round | IPO | Not published |
| LinkedIn followers | 37,705 | 6,563 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Avidity Biosciences | Cellcolabs |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 55/100 |
| Traction | 60/100 | Not published |
| Search visibility | 22/100 | 2/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Avidity Biosciences | Cellcolabs |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Tag Manager | Google Tag Manager |
Avidity Biosciences vs Cellcolabs: common questions
Which is better, Avidity Biosciences or Cellcolabs?
On our 0-100 score Cellcolabs rates higher (55/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Avidity Biosciences and Cellcolabs compare on the numbers?
Avidity Biosciences leads on domain rating (46/100 against 37/100), headcount (445 against 79), funding raised ($495M against $15.5M), LinkedIn following (37,705 against 6,563).
Read the full Avidity Biosciences review and pricing or the Cellcolabs review and pricing. You can also browse other Avidity Biosciences alternatives we track.